Rituximab Significantly Reduces Renal Injury in Membranous Nephropathy
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Rituximab Significantly Reduces Renal Injury in Membranous Nephropathy

Washington, DC -- August 6, 2008 -- Rituximab significantly reduces the amount of kidney injury in patients with membranous nephropathy, according to a study appearing in the November 2008 issue of the Clinical Journal of the American Society of Nephrology.

The results suggest that this condition, previously destined to progress to kidney failure in 30% to 40% of cases, can actually be healed in some patients.

Piero Ruggenenti, MD, Negri Bergamo Laboratories, Bergamo, Italy, and colleagues, treated 50 patients with membranous nephropathy with rituximab.

Researchers found that 10 of the patients eventually achieved a complete remission of their disease, 7 of whom provided consent to participate in further evaluations, including additional kidney biopsies.

In these patients, deposits of autoantibodies eventually disappeared or were almost entirely reabsorbed, and the damage originally noted in certain kidney structures significantly healed.

"This represents the first demonstration that kidney injury in membranous nephropathy can regress after selective depletion of B cells. Thus, the present data provide a strong rationale for using rituximab to treat patients with membranous nephropathy," said Dr. Ruggenenti.

"Whether this may apply to other [similar kidney conditions] and may translate into long-term protection from renal function loss and the potentially life-threatening complications … remains to be established," the authors wrote.

SOURCE: American Society of Nephrology

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities